Detalhe da pesquisa
1.
Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer.
Proc Natl Acad Sci U S A
; 121(6): e2304619121, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289962
2.
EZH2 mediated metabolic rewiring promotes tumor growth independently of histone methyltransferase activity in ovarian cancer.
Mol Cancer
; 22(1): 85, 2023 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210576
3.
Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of MYC expression.
Oncogene
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38783101
4.
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.
Clin Epigenetics
; 15(1): 19, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36740715
5.
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer.
J Clin Invest
; 132(22)2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36201246
6.
Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer.
Adv Sci (Weinh)
; 8(23): e2100759, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881526
7.
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer.
J Clin Invest
; 131(20)2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464356
8.
CREBBP cooperates with the cell cycle machinery to attenuate chidamide sensitivity in relapsed/refractory diffuse large B-cell lymphoma.
Cancer Lett
; 521: 268-280, 2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481935